Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $135M Series B led by Sanofi Ventures and EQT (Jun 2025). First patient dosed in Phase 1/2 for Stargardt disease (Jan 2026). Overcomes 4.7kb AAV cargo limit.
SpliceBio is a gene therapy company whose protein trans-splicing platform overcomes the 4.7-kilobase cargo limit of adeno-associated viral (AAV) vectors — the primary delivery vehicle for gene therapy — unlocking treatments for large-gene diseases previously untreatable. The company raised $135 million in Series B financing co-led by Sanofi Ventures and EQT Life Sciences in June 2025, and dosed its first patient in Phase 1/2 Part B for SB-007 in Stargardt disease in January 2026.
2024 Revenue: KRW 175.2T (+7.7% YoY) | Operating Profit: KRW 14.2T (-5.9%) | Vehicle Sales: 4.14M units (-1.8%) | Q4 2024: Revenue KRW 46.62T (+11.9%), Op Profit KRW 2.82T (-17.2%) | Electrified Vehicles: 757k units (+8.9%, 21.8% of sales) | US Market: 988k units (+9%) | 2025 guidance: 3-4% revenue growth, 7-8% op margin
Hyundai Motor Company was founded in 1967 in Seoul, South Korea, by Chung Ju-yung and has grown into one of the world's largest automotive manufacturers, ranking third globally by vehicle sales. From its origins as a budget-focused automaker producing affordable, practical vehicles for emerging markets, Hyundai has transformed over the past two decades into a technology-forward brand competing directly with European and Japanese premium manufacturers. Its mission centers on delivering smart mobility solutions for a sustainable future.\n\nHyundai's product lineup spans mass-market sedans, SUVs, and commercial vehicles, alongside its premium Genesis brand and the Ioniq dedicated EV lineup. The Ioniq 5, Ioniq 6, and Ioniq 7 have emerged as critically acclaimed electric vehicles, with the Ioniq 5 winning the World Car of the Year award. Hyundai is also investing heavily in hydrogen fuel cell technology, autonomous driving, and robotics through subsidiaries including Boston Dynamics. Its vehicles are sold in over 200 countries through a network of more than 6,000 dealerships.\n\nHyundai reported revenue of KRW 175.2 trillion in 2024, a 7.7% year-over-year increase, with Q4 2024 revenue of KRW 46.62T (+11.9%). The company sold 4.14M vehicles globally in 2024. With major EV manufacturing investments underway in the United States (Metaplant America in Georgia), Hyundai is positioning itself to be a top-three EV manufacturer globally by 2030, backed by robust R&D spending and a vertically integrated battery and platform strategy.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.